{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:42:11Z","timestamp":1790818931516,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["#ANR-17-EURE-0013"],"award-info":[{"award-number":["#ANR-17-EURE-0013"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Theileria<\/jats:italic> parasites are responsible for devastating cattle diseases, causing major economic losses across Africa and Asia. <jats:italic>Theileria<\/jats:italic> spp. stand apart from other apicomplexa parasites by their ability to transform host leukocytes into immortalized, hyperproliferating, invasive cells that rapidly kill infected animals. The emergence of resistance to the theilericidal drug Buparvaquone raises the need for new anti-<jats:italic>Theileria<\/jats:italic> drugs. We developed a microscopy-based screen to reposition drugs from the open-access Medicines for Malaria Venture (MMV) Pathogen Box. We show that Trifloxystrobin (MMV688754) selectively kills lymphocytes or macrophages infected with <jats:italic>Theileria annulata<\/jats:italic> or <jats:italic>Theileria parva<\/jats:italic> parasites. Trifloxystrobin treatment reduced parasite load in vitro as effectively as Buparvaquone, with similar effects on host gene expression, cell proliferation and cell cycle. Trifloxystrobin also inhibited parasite differentiation to merozoites (merogony). Trifloxystrobin inhibition of parasite survival is independent of the parasite TaPin1 prolyl isomerase pathway. Furthermore, modeling studies predicted that Trifloxystrobin and Buparvaquone could interact distinctly with parasite Cytochrome B and we show that Trifloxystrobin was still effective against Buparvaquone-resistant cells harboring <jats:italic>TaCytB<\/jats:italic> mutations. Our study suggests that Trifloxystrobin could provide an effective alternative to Buparvaquone treatment and represents a promising candidate for future drug development against <jats:italic>Theileria<\/jats:italic> spp.<\/jats:p>","DOI":"10.1038\/s42003-022-03981-x","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T18:14:57Z","timestamp":1668536097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Trifloxystrobin blocks the growth of Theileria parasites and is a promising drug to treat Buparvaquone resistance"],"prefix":"10.1038","volume":"5","author":[{"given":"Marie","family":"Villares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Berthelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Lamotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Regad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souhila","family":"Medjkane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Prina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rodrigues-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0256-2029","authenticated-orcid":false,"given":"Gerald F.","family":"Sp\u00e4th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Weitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"3981_CR1","first-page":"284","volume":"66","author":"RL Spooner","year":"1989","unstructured":"Spooner, R. L., Innes, E. A., Glass, E. J. & Brown, C. G. D. Theileria annulata and T. parva infect and transform different bovine mononuclear cells. Immunol 66, 284\u2013288 (1989).","journal-title":"Immunol"},{"key":"3981_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1017\/S0031182009990916","volume":"136","author":"WI Morrison","year":"2009","unstructured":"Morrison, W. I. Progress towards understanding the immunobiology of Theileria parasites. Parasitology 136, 1415\u20131426 (2009).","journal-title":"Parasitology"},{"key":"3981_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0169-4758(85)90056-0","volume":"1","author":"AD Irvin","year":"1985","unstructured":"Irvin, A. D. Immunity in theileriosis. Parasitol. Today 1, 124\u2013128 (1985).","journal-title":"Parasitol. Today"},{"key":"3981_CR4","doi-asserted-by":"publisher","first-page":"e1005763","DOI":"10.1371\/journal.ppat.1005763","volume":"12","author":"WC Van Voorhis","year":"2016","unstructured":"Van Voorhis, W. C. et al. Open source drug discovery with the Malaria box compound collection for neglected diseases and beyond. PLoS Pathog. 12, e1005763 (2016).","journal-title":"PLoS Pathog."},{"key":"3981_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0034-5288(18)31765-X","volume":"39","author":"N McHardy","year":"1985","unstructured":"McHardy, N., Wekesa, L. S., Hudson, A. T. & Randall, A. W. Antitheilerial activity of BW720C (buparvaquone): a comparison with parvaquone. Res. Vet. Sci. 39, 29\u201333 (1985).","journal-title":"Res. Vet. Sci."},{"key":"3981_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature14044","volume":"520","author":"J Marsolier","year":"2015","unstructured":"Marsolier, J. et al. Theileria parasites secrete a prolyl isomerase to maintain host leukocyte transformation. Nature 520, 378\u2013382 (2015).","journal-title":"Nature"},{"key":"3981_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijpddr.2019.11.001","volume":"11","author":"B Salim","year":"2019","unstructured":"Salim, B. et al. Mutations in the TaPIN1 peptidyl prolyl isomerase gene in Theileria annulata parasites isolated in Sudan. Int. J. Parasitol. Drugs Drug Resist. 11, 101\u2013105 (2019).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"3981_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.vetpar.2010.01.013","volume":"169","author":"M Mhadhbi","year":"2010","unstructured":"Mhadhbi, M. et al. In vivo evidence for the resistance of Theileria annulata to buparvaquone. Vet. Parasitol. 169, 241\u2013247 (2010).","journal-title":"Vet. Parasitol."},{"key":"3981_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.actatropica.2018.12.041","volume":"191","author":"E Chatanga","year":"2019","unstructured":"Chatanga, E. et al. Evidence of multiple point mutations in Theileria annulata cytochrome b gene incriminated in buparvaquone treatment failure. Acta Trop. 191, 128\u2013132 (2019).","journal-title":"Acta Trop."},{"key":"3981_CR10","doi-asserted-by":"publisher","first-page":"e0129678","DOI":"10.1371\/journal.pone.0129678","volume":"10","author":"M Mhadhbi","year":"2015","unstructured":"Mhadhbi, M., Chaouch, M., Ajroud, K., Darghouth, M. A. & BenAbderrazak, S. Sequence polymorphism of cytochrome b gene in theileria annulata tunisian isolates and its association with Buparvaquone treatment failure. PLoS One 10, e0129678 (2015).","journal-title":"PLoS One"},{"key":"3981_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pt.2015.04.001","volume":"31","author":"K Tretina","year":"2015","unstructured":"Tretina, K., Gotia, H. T., Mann, D. J. & Silva, J. C. Theileria-transformed bovine leukocytes have cancer hallmarks. Trends Parasitol. 31, 306\u2013314 (2015).","journal-title":"Trends Parasitol."},{"key":"3981_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00281-020-00779-z","volume":"42","author":"M Villares","year":"2020","unstructured":"Villares, M., Berthelet, J. & Weitzman, J. B. The clever strategies used by intracellular parasites to hijack host gene expression. Semin. Immunopathol. 42, 215\u2013226 (2020).","journal-title":"Semin. Immunopathol."},{"key":"3981_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/cmi.12471","volume":"17","author":"K Cheeseman","year":"2015","unstructured":"Cheeseman, K. & Weitzman, J. B. Host-parasite interactions: an intimate epigenetic relationship. Cell. Microbiol. 17, 1121\u20131132 (2015).","journal-title":"Cell. Microbiol."},{"key":"3981_CR14","doi-asserted-by":"publisher","first-page":"e12973","DOI":"10.1111\/cmi.12973","volume":"21","author":"P Latr\u00e9 De Lat\u00e9","year":"2019","unstructured":"Latr\u00e9 De Lat\u00e9, P. et al. Theileria highjacks JNK2 into a complex with the macroschizont GPI (GlycosylPhosphatidylInositol)-anchored surface protein p104. Cell. Microbiol. 21, e12973 (2019).","journal-title":"Cell. Microbiol."},{"key":"3981_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/sj.onc.1208314","volume":"24","author":"F Dessauge","year":"2005","unstructured":"Dessauge, F. et al. c-Myc activation by Theileria parasites promotes survival of infected B-lymphocytes. Oncogene 24, 1075\u20131083 (2005).","journal-title":"Oncogene"},{"key":"3981_CR16","doi-asserted-by":"publisher","first-page":"e1003346","DOI":"10.1371\/journal.ppat.1003346","volume":"9","author":"KL Woods","year":"2013","unstructured":"Woods, K. L. et al. Recruitment of EB1, a master regulator of microtubule dynamics, to the surface of the Theileria annulata Schizont. PLoS Pathog. 9, e1003346 (2013).","journal-title":"PLoS Pathog."},{"key":"3981_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1126\/science.1075462","volume":"298","author":"VT Heussler","year":"2002","unstructured":"Heussler, V. T. et al. Hijacking of host cell IKK signalosomes by the transforming parasite Theileria. Science 298, 1033\u20131036 (2002).","journal-title":"Science"},{"key":"3981_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/boc.202000096","volume":"113","author":"S Tajeri","year":"2021","unstructured":"Tajeri, S. & Langsley, G. Theileria secretes proteins to subvert its host leukocyte. Biol. Cell 113, 220\u2013233 (2021).","journal-title":"Biol. Cell"},{"key":"3981_CR19","doi-asserted-by":"publisher","first-page":"662805","DOI":"10.3389\/fcell.2021.662805","volume":"9","author":"K Woods","year":"2021","unstructured":"Woods, K., Perry, C., Br\u00fchlmann, F. & Olias, P. Theileria\u2019s strategies and effector mechanisms for host cell transformation: from invasion to immortalization. Front. Cell Developmental Biol. 9, 662805 (2021).","journal-title":"Front. Cell Developmental Biol."},{"key":"3981_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fcell.2020.00134","volume":"8","author":"S Medjkane","year":"2020","unstructured":"Medjkane, S. & Weitzman, J. B. Intracellular Theileria parasites PIN down host metabolism. Front. Cell Dev. Biol. 8, 134 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"3981_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s42003-019-0386-6","volume":"2","author":"J Marsolier","year":"2019","unstructured":"Marsolier, J., Perichon, M., Weitzman, J. B. & Medjkane, S. Secreted parasite Pin1 isomerase stabilizes host PKM2 to reprogram host cell metabolism. Commun. Biol. 2, 152 (2019).","journal-title":"Commun. Biol."},{"key":"3981_CR22","first-page":"e00215","volume":"2","author":"S Huber","year":"2017","unstructured":"Huber, S. et al. The microtubule-stabilizing protein CLASP1 associates with the Theileria annulata schizont surface via its Kinetochore-binding domain. mSphere 2, e00215\u2013e00217 (2017).","journal-title":"mSphere"},{"key":"3981_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23477-2","volume":"12","author":"K Cheeseman","year":"2021","unstructured":"Cheeseman, K. et al. Dynamic methylation of histone H3K18 in differentiating Theileria parasites. Nat. Commun. 12, 3221 (2021).","journal-title":"Nat. Commun."},{"key":"3981_CR24","doi-asserted-by":"crossref","unstructured":"Lamotte, S., Aulner, N., Sp\u00e4th, G. F. & Prina, E. Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening. Sci. Rep. 9, 438 (2019).","DOI":"10.1038\/s41598-018-36944-6"},{"key":"3981_CR25","doi-asserted-by":"publisher","first-page":"e1003222","DOI":"10.1371\/journal.ppat.1003222","volume":"9","author":"J Marsolier","year":"2013","unstructured":"Marsolier, J. et al. OncomiR addiction is generated by a miR-155 feedback loop in Theileria-transformed leukocytes. PLoS Pathog. 9, e1003222 (2013).","journal-title":"PLoS Pathog."},{"key":"3981_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijpddr.2019.01.002","volume":"9","author":"J Nyagwange","year":"2019","unstructured":"Nyagwange, J. et al. Leveraging the medicines for Malaria Venture malaria and pathogen boxes to discover chemical inhibitors of East Coast fever. Int. J. Parasitol. Drugs Drug Resist. 9, 80\u201386 (2019).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"3981_CR27","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1128\/AAC.02801-15","volume":"60","author":"I Hostettler","year":"2016","unstructured":"Hostettler, I., M\u00fcller, J. & Hemphill, A. In vitro screening of the open-source medicines for malaria venture malaria box reveals novel compounds with profound activities against theileria annulata schizonts. Antimicrob. Agents Chemother. 60, 3301\u20133308 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"3981_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijpddr.2019.06.004","volume":"10","author":"AB Nugraha","year":"2019","unstructured":"Nugraha, A. B. et al. Screening the medicines for Malaria venture pathogen box against piroplasm parasites. Int. J. Parasitol. Drugs Drug Resist. 10, 84\u201390 (2019).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"3981_CR29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1158\/0008-5472.CAN-11-1052","volume":"72","author":"AM Cock-Rada","year":"2012","unstructured":"Cock-Rada, A. M. et al. SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9. Cancer Res. 72, 810\u2013820 (2012).","journal-title":"Cancer Res."},{"key":"3981_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpddr.2014.09.003","volume":"4","author":"I Hostettler","year":"2014","unstructured":"Hostettler, I., M\u00fcller, J., Stephens, C. E., Haynes, R. & Hemphill, A. A quantitative reverse-transcriptase PCR assay for the assessment of drug activities against intracellular Theileria annulata schizonts. Int. J. Parasitol. Drugs Drug Resist. 4, 201\u2013209 (2014).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"3981_CR31","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/onc.2013.134","volume":"33","author":"S Medjkane","year":"2014","unstructured":"Medjkane, S., Perichon, M., Marsolier, J., Dairou, J. & Weitzman, J. B. Theileria induces oxidative stress and HIF1\u03b1 activation that are essential for host leukocyte transformation. Oncogene 33, 1809\u20131817 (2014).","journal-title":"Oncogene"},{"key":"3981_CR32","doi-asserted-by":"crossref","unstructured":"Chaussepied, M. et al. TGF-b2 induction regulates invasiveness of Theileria-transformed leukocytes and disease susceptibility. PLoS Pathog. 6, e1001197 (2010).","DOI":"10.1371\/journal.ppat.1001197"},{"key":"3981_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/cmi.12421","volume":"17","author":"M Metheni","year":"2015","unstructured":"Metheni, M., Lomb\u00e8s, A., Bouillaud, F., Batteux, F. & Langsley, G. HIF-1\u03b1 induction, proliferation and glycolysis of Theileria-infected leukocytes. Cell. Microbiol. 17, 467\u2013472 (2015).","journal-title":"Cell. Microbiol."},{"key":"3981_CR34","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ijpara.2008.05.009","volume":"38","author":"J Schmuckli-Maurer","year":"2008","unstructured":"Schmuckli-Maurer, J., Shiels, B. & Dobbelaere, D. A. Stochastic induction of Theileria annulata merogony in vitro by chloramphenicol. Int. J. Parasitol. 38, 1705\u20131715 (2008).","journal-title":"Int. J. Parasitol."},{"key":"3981_CR35","doi-asserted-by":"crossref","unstructured":"Sharifiyazdi, H., Namazi, F., Oryan, A., Shahriari, R. & Razavi, M. Point mutations in the Theileria annulata cytochrome b gene is associated with buparvaquone treatment failure. Vet. Parasitol. 187, 431\u2013435 (2012).","DOI":"10.1016\/j.vetpar.2012.01.016"},{"key":"3981_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/03601230701316465","volume":"42","author":"H Balba","year":"2007","unstructured":"Balba, H. Review of strobilurin fungicide chemicals. J. Environ. Sci. Health B. 42, 441\u2013451 (2007).","journal-title":"J. Environ. Sci. Health B."},{"key":"3981_CR37","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1002\/ps.5990","volume":"76","author":"J Miao","year":"2020","unstructured":"Miao, J. et al. Three point-mutations in cytochrome b confer resistance to trifloxystrobin in Magnaporthe oryzae. Pest Manag. Sci. 76, 4258\u20134267 (2020).","journal-title":"Pest Manag. Sci."},{"key":"3981_CR38","first-page":"1","volume":"5","author":"GF Hao","year":"2015","unstructured":"Hao, G. F. et al. Rational design of highly potent and slow-binding cytochrome bc1 inhibitor as fungicide by computational substitution optimization. Sci. Rep. 2015 51 5, 1\u201310 (2015).","journal-title":"Sci. Rep. 2015 51"},{"key":"3981_CR39","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res"},{"key":"3981_CR40","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03981-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03981-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03981-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T04:35:31Z","timestamp":1668573331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03981-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3981"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-03981-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"10 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1253"}}